Caregivers and healthy ageing with HIV in low-income and middle-income countries [0.03%]
照料者与低收入和中等收入国家HIV感染者的健康老龄化问题
Jepchirchir Kiplagat,Daniel O Ofuwo
Jepchirchir Kiplagat
Amy C Justice,Keri N Althoff,A Mark Clarfield et al.
Amy C Justice et al.
Eugenia L Siegler,Atami S De Main,Emily E Frey et al.
Eugenia L Siegler et al.
100% committed to life [0.03%]
全心投入生活
Ed Holt
Ed Holt
HIV acquisitions, safety, and pharmacokinetics of lenacapavir for HIV pre-exposure prophylaxis in pregnant and lactating women (PURPOSE 1): a substudy of a phase 3, randomised controlled trial [0.03%]
用于孕妇和哺乳期女性的恩卡潘韦HIV暴露前预防的有效性、安全性和药动学（目的1）：III期随机对照试验中的一个子研究
Linda-Gail Bekker,Dhayendre Moodley,Dazon Dixon Diallo et al.
Linda-Gail Bekker et al.
Background: Lenacapavir demonstrated high efficacy and safety as pre-exposure prophylaxis (PrEP) in cisgender women, but its use during pregnancy and lactation when women are disproportionately vulnerable to HIV acquisiti...
Joe Daniels
Joe Daniels
Paul Adepoju
Paul Adepoju
Expanding access to lenacapavir in low-income and middle-income countries [0.03%]
在中低收入国家扩大利那卡帕韦的使用范围
Nam T Nguyen,Faraan O Rahim,Goodluck Valence et al.
Nam T Nguyen et al.
Lauren B Beach,Benjamin Young,Craig Davenport et al.
Lauren B Beach et al.